Application of Raman spectroscopy in the detection of hepatitis B virus infection

Detection of hepatitis B virus (HBV) using Raman spectroscopy.

Raman spectroscopy was used to examine the serum samples of 500 patients with HBV and 500 non-HBV persons. First, the adaptive iterative weighted penalty least squares method (airPLS) was used to deduct the fluorescence background in Raman spectra. Then, a principal component analysis (PCA) was used to extract the processed Raman spectra, and a support vector machine (SVM) was used for modeling and prediction. The particle swarm optimization (PSO) algorithm was selected to optimize the parameters of the SVM instead of a traditional grid search. Finally, 600 serum samples were detected by Raman spectroscopy, and the results wereverified using a double-blind method.

In the Raman spectra, the non-HBV human Raman peaks at 509, 957, 1002, 1153, 1260, 1512, 1648 and 2305 cm^-1 were different from those of patients with HBV. The reported accuracy, sensitivity and specificity of the HBV serum model established using airPLS-PCA-PSO-SVM was 93.1%, 100% and 88%, respectively. The two groups were verified by a double-blind method. In the first group sensitivity was 87%, specificity was 92%, and the KAPPA value was 0.79; in the second group sensitivity was 80%, specificity was 79%, and the KAPPA value was 0.59.

This preliminary study shows that serum Raman spectroscopy combined with the airPLS-PCA-PSO-SVM model can be used for hepatitis B virus detection.